EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets

Gi-Eun Yang, Seo-Yeong Yoon, Ju-Seog Lee, Sun-Hee Leem iD, Yung-Hyun Choi

Genes & Genomics · 2026-02 · 48 (2) · 173-184

DOI: 10.1007/s13258-025-01710-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes & Genomics, online erschienen am 26.11.2025. Verfasst von Gi-Eun Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Dong-A University, Busan, 49315, Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Resistance, Neoplasm, Urologic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance remains a major challenge in the management of urologic cancers, including renal cell carcinoma (RCC), bladder cancer (BC), and prostate cancer (PCa). Recent advances highlight the tumor microenvironment (TME) as a critical determinant of treatment failure across various modalities, such as androgen deprivation therapy (ADT), VEGF-targeted therapies, and immune checkpoint inhibitors (ICIs). This review summarizes how distinct TME components-such as cancer-associated fibroblasts (CAFs), extracellular matrix (ECM), immunosuppressive cells, and hypoxic conditions-promote resistance. CAFs drive oncogenic reactivation and epithelial-mesenchymal transition (EMT), while ECM stiffening hinders immune infiltration and facilitates pro-survival signaling. Immune evasion mechanisms include TGF-β-mediated T cell exclusion, regulatory T cell expansion, and adaptive checkpoint upregulation. Hypoxia and metabolic reprogramming further promote cancer stemness and immune suppression through HIF-2α activation, lactate accumulation, and acidification of TME. Targeting these resistance mechanisms requires a multifaceted approach. Promising strategies include ICI combination therapies with anti-angiogenics or TGF-β inhibitors, ECM-modulating agents, and hypoxia-targeted drugs. Novel approaches such as single-cell and spatial transcriptomics, organoid co-culture systems, and TME-derived biomarkers offer new opportunities for patient stratification and therapeutic development. Integrating TME biology into clinical practice is essential to overcome resistance and improve outcomes in urologic oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentDrug Resistance, NeoplasmUrologic NeoplasmsHumansEpithelial-Mesenchymal TransitionCancer-Associated Fibroblasts

Stichwörter der Autor:innen

Cancer-associated fibroblasts (CAFs)Combination therapyImmune evasionTherapeutic resistanceTumor microenvironment (TME)Urologic cancers

Autor:innen und Institutionen

  • Department of Biomedical Science, Dong-A University, Busan, 49315, Korea.
  • Department of Health Sciences, The Graduated of Dong-A University, Busan, 49315, Korea.
  • Department of Systems Biology, Division of Basic Science, The University of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA. jlee@mdanderson.org.
  • Department of Biomedical Science, Dong-A University, Busan, 49315, Korea. shleem@dau.ac.kr.
  • Department of Health Sciences, The Graduated of Dong-A University, Busan, 49315, Korea. shleem@dau.ac.kr.
  • Department of Biochemistry, College of Oriental Medicine, Anti-Aging Research Center, Dong-Eui University, Busan, 47227, Korea. choiyh@deu.ac.kr.

ORCID-Profile: Sun-Hee Leem

Förderung

  • NCI NIH HHS

Zitieren

APA

Yang, G. E., Yoon, S. Y., Lee, J. S., Leem, S. H., & Choi, Y. H. (2026). Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets. Genes & Genomics, 48(2), 173-184. https://doi.org/10.1007/s13258-025-01710-2

Vancouver

Yang GE, Yoon SY, Lee JS, Leem SH, Choi YH. Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets. Genes & Genomics. 2026;48(2):173-184. doi:10.1007/s13258-025-01710-2

BibTeX
@article{Yang2026,
  author = {Yang, Gi-Eun and Yoon, Seo-Yeong and Lee, Ju-Seog and Leem, Sun-Hee and Choi, Yung-Hyun},
  title = {Tumor microenvironment-driven drug resistance in urologic cancers: mechanisms and therapeutic targets},
  journal = {Genes & Genomics},
  year = {2026},
  volume = {48},
  number = {2},
  pages = {173--184},
  doi = {10.1007/s13258-025-01710-2}
}
Kostenlos starten →